VIM
CVS icon

Veritas Investment Management’s CVS Health CVS Stock Holding History

Veritas Investment Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,545
Closed -$149K – 15
2020
Q3 		$149K Hold
2,545
– – 0.01% 49
2020
Q2 		$165K Hold
2,545
– – 0.01% 46
2020
Q1 		$151K Hold
2,545
– – 0.01% 51
2019
Q4 		$189K Sell
2,545
-350
-12% -$24.6K 0.01% 44
2019
Q3 		$183K Hold
2,895
– – 0.02% 50
2019
Q2 		$158K Sell
2,895
-816,924
-100% -$44M 0.01% 43
2019
Q1 		$44.2M Sell
819,819
-11,425
-1% -$705K 4.32% 12
2018
Q4 		$54.5M Buy
831,244
+29,820
+4% +$2.23M 6.63% 9
2018
Q3 		$63.1M Buy
801,424
+17,420
+2% +$1.25M 6.65% 9
2018
Q2 		$50.4M Buy
784,004
+87,115
+13% +$5.74M 6.26% 9
2018
Q1 		$43.4M Sell
696,889
-22,039
-3% -$1.58M 5.55% 9
2017
Q4 		$52.2M Buy
718,928
+4,220
+0.6% +$307K 7.22% 8
2017
Q3 		$58.1M Buy
714,708
+53,785
+8% +$4.25M 7.86% 7
2017
Q2 		$53.2M Buy
660,923
+82,637
+14% +$6.53M 7.77% 6
2017
Q1 		$45.4M Buy
578,286
+20,995
+4% +$1.68M 7.47% 6
2016
Q4 		$44M Buy
557,291
+37,125
+7% +$3M 7.78% 6
2016
Q3 		$46.3M Buy
520,166
+27,990
+6% +$2.64M 8.69% 4
2016
Q2 		$47.1M Buy
492,176
+13,010
+3% +$1.3M 9.09% 4
2016
Q1 		$49.7M Buy
479,166
+34,420
+8% +$3.35M 9.72% 4
2015
Q4 		$43.5M Buy
444,746
+95,335
+27% +$9.34M 8.3% 4
2015
Q3 		$28.8M Buy
349,411
+195,685
+127% +$20.6M 7.57% 6
2015
Q2 		$11.4M Buy
153,726
+6,396
+4% +$653K 3.22% 11
2015
Q1 		$10.8M Buy
147,330
+100,430
+214% +$10.2M 3.59% 10
2014
Q4 		$4.52M Sell
46,900
-95,460
-67% -$8.41M 8.12% 5
2014
Q3 		$11.3M Buy
142,360
+2,510
+2% +$198K 3.69% 11
2014
Q2 		$10.5M Buy
139,850
+5,050
+4% +$382K 3.63% 9
2014
Q1 		$10.1M Buy
134,800
+4,650
+4% +$328K 3.93% 10
2013
Q4 		$9.31M Buy
130,150
+18,290
+16% +$1.18M 4.45% 8
2013
Q3 		$6.35M Buy
111,860
+260
+0.2% +$15.5K 3.69% 9
2013
Q2 		$6.38M Buy
+111,600
New +$6.47M 4.11% 9

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Veritas Investment Management's CVS Position: Q4 2020 in Review

Veritas Investment Management sold out of CVS Health (CVS) in Q4 2020, closing a stake of 2,545 shares — an estimated $149K sold.

Veritas Investment Management first reported a position in CVS in Q2 2013 and held it in 30 quarters. The position peaked at $63.1M in Q3 2018. 1,972 funds tracked by Wall St. Rank hold CVS as of Q4 2020.

  • Veritas Investment Management reported no remaining CVS Health position as of Q4 2020 after selling out during the quarter.
  • Veritas Investment Management sold 2,545 CVS Health shares in Q4 2020, an estimated $149K.
  • Veritas Investment Management first reported a position in CVS Health in Q2 2013 and held it in 30 quarters.
  • Veritas Investment Management's CVS Health position peaked at $63.1M in Q3 2018.
  • 1,972 funds tracked by Wall St. Rank held CVS Health as of Q4 2020.

Based on Veritas Investment Management's 13F filing for Q4 2020.